Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 422.39% vs 0.00% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is -84.62% vs -53.57% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is 23.50% vs -22.19% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 24.55% vs 5.12% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 11.12% vs 10.05% in Mar 2024
Compare Balance Sheet Results of Anuh Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
25.06
32.77
-7.71
-23.53%
Share Warrants & Outstandings
Total Reserve
300.97
18.64
282.33
1,514.65%
Shareholder's Funds
326.02
59.27
266.75
450.06%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
160.29
-160.29
-100.00%
Secured Loans
0.00
160.29
-160.29
-100.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-2.08
-7.04
4.96
70.45%
Other Long Term Liabilities
0.06
2.29
-2.23
-97.38%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
2.03
17.45
-15.42
-88.37%
Total Non-Current Liabilities
0.01
173.00
-172.99
-99.99%
Current Liabilities
Trade Payables
156.84
138.46
18.38
13.27%
Other Current Liabilities
11.00
20.66
-9.66
-46.76%
Short Term Borrowings
10.50
12.94
-2.44
-18.86%
Short Term Provisions
0.17
2.56
-2.39
-93.36%
Total Current Liabilities
178.51
174.61
3.90
2.23%
Total Liabilities
504.55
406.88
97.67
24.00%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
111.06
271.51
-160.45
-59.10%
Less: Accumulated Depreciation
61.36
81.60
-20.24
-24.80%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
49.70
189.92
-140.22
-73.83%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.27
5.38
-5.11
-94.98%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
51.95
0.02
51.93
259,650.00%
Long Term Loans & Advances
2.64
5.90
-3.26
-55.25%
Other Non Current Assets
15.30
1.53
13.77
900.00%
Total Non-Current Assets
128.38
213.44
-85.06
-39.85%
Current Assets Loans & Advances
Current Investments
53.86
0.13
53.73
41,330.77%
Inventories
74.48
37.68
36.80
97.66%
Sundry Debtors
215.87
114.16
101.71
89.09%
Cash and Bank
19.74
12.83
6.91
53.86%
Other Current Assets
11.48
21.47
-9.99
-46.53%
Short Term Loans and Advances
0.75
7.18
-6.43
-89.55%
Total Current Assets
376.17
193.44
182.73
94.46%
Net Current Assets (Including Current Investments)
197.66
18.83
178.83
949.71%
Total Current Assets Excluding Current Investments
322.31
193.31
129.00
66.73%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
504.55
406.88
97.67
24.00%
Contingent Liabilities
25.26
65.85
-40.59
-61.64%
Total Debt
10.50
173.23
-162.73
-93.94%
Book Value per share (adjusted)
32.53
16.26
16.27
100.06%
Annual - Borrowings
Borrowings 10.50 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 422.39% vs 0.00% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.06 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -84.62% vs -53.57% in Mar 2024
Annual - Fixed Assets
Fixed Assets 49.97 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 23.50% vs -22.19% in Mar 2024
Annual - Investments
Investments 51.95 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 24.55% vs 5.12% in Mar 2024
Annual - Current Assets
Current Assets 376.17 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 11.12% vs 10.05% in Mar 2024






